450 related articles for article (PubMed ID: 28670306)
1. Complement Evasion Strategies of Viruses: An Overview.
Agrawal P; Nawadkar R; Ojha H; Kumar J; Sahu A
Front Microbiol; 2017; 8():1117. PubMed ID: 28670306
[TBL] [Abstract][Full Text] [Related]
2. Virus-Encoded Complement Regulators: Current Status.
Sinha A; Singh AK; Kadni TS; Mullick J; Sahu A
Viruses; 2021 Jan; 13(2):. PubMed ID: 33573085
[TBL] [Abstract][Full Text] [Related]
3. In the Crosshairs: RNA Viruses OR Complement?
Kumar NA; Kunnakkadan U; Thomas S; Johnson JB
Front Immunol; 2020; 11():573583. PubMed ID: 33133089
[TBL] [Abstract][Full Text] [Related]
4. Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.
Murugaiah V; Varghese PM; Beirag N; De Cordova S; Sim RB; Kishore U
Viruses; 2021 May; 13(5):. PubMed ID: 34063241
[TBL] [Abstract][Full Text] [Related]
5. Flaviviridae virus nonstructural proteins 5 and 5A mediate viral immune evasion and are promising targets in drug development.
Chen S; Yang C; Zhang W; Mahalingam S; Wang M; Cheng A
Pharmacol Ther; 2018 Oct; 190():1-14. PubMed ID: 29742479
[TBL] [Abstract][Full Text] [Related]
6. The imitation game: a viral strategy to subvert the complement system.
Agrawal P; Sharma S; Pal P; Ojha H; Mullick J; Sahu A
FEBS Lett; 2020 Aug; 594(16):2518-2542. PubMed ID: 32506518
[TBL] [Abstract][Full Text] [Related]
7. The role of antibody and complement in the control of viral infections.
Cooper NR; Nemerow GR
J Invest Dermatol; 1984 Jul; 83(1 Suppl):121s-127s. PubMed ID: 6376646
[TBL] [Abstract][Full Text] [Related]
8. Viral immune evasion: a masterpiece of evolution.
Vossen MT; Westerhout EM; Söderberg-Nauclér C; Wiertz EJ
Immunogenetics; 2002 Nov; 54(8):527-42. PubMed ID: 12439615
[TBL] [Abstract][Full Text] [Related]
9. Viral mimicry of the complement system.
Bernet J; Mullick J; Singh AK; Sahu A
J Biosci; 2003 Apr; 28(3):249-64. PubMed ID: 12734404
[TBL] [Abstract][Full Text] [Related]
10. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
[TBL] [Abstract][Full Text] [Related]
11. Virus complement evasion strategies.
Favoreel HW; Van de Walle GR; Nauwynck HJ; Pensaert MB
J Gen Virol; 2003 Jan; 84(Pt 1):1-15. PubMed ID: 12533696
[TBL] [Abstract][Full Text] [Related]
12. RNA-virus proteases counteracting host innate immunity.
Lei J; Hilgenfeld R
FEBS Lett; 2017 Oct; 591(20):3190-3210. PubMed ID: 28850669
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR).
Goodman DE; Pretto CD; Krepostman TA; Carnahan KE; Spindler KR
mBio; 2019 Apr; 10(2):. PubMed ID: 31015330
[TBL] [Abstract][Full Text] [Related]
14. A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.
Johnson JB; Borisevich V; Rockx B; Parks GD
J Virol; 2015 Jan; 89(2):989-98. PubMed ID: 25355897
[TBL] [Abstract][Full Text] [Related]
15. Viral regulators of complement activation: structure, function and evolution.
Ojha H; Panwar HS; Gorham RD; Morikis D; Sahu A
Mol Immunol; 2014 Oct; 61(2):89-99. PubMed ID: 24976595
[TBL] [Abstract][Full Text] [Related]
16. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
[TBL] [Abstract][Full Text] [Related]
17. CHEMISTRY AND STRUCTURE OF ANIMAL VIRUS PARTICLES.
GREEN M
Am J Med; 1965 May; 38():651-68. PubMed ID: 14286805
[No Abstract] [Full Text] [Related]
18. Viral complement regulators: the expert mimicking swindlers.
Ahmad M; Pyaram K; Mullick J; Sahu A
Indian J Biochem Biophys; 2007 Oct; 44(5):331-43. PubMed ID: 18341208
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the C5-C5a receptor axis.
Woodruff TM; Nandakumar KS; Tedesco F
Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
[TBL] [Abstract][Full Text] [Related]
20. Innate immune response and viral interference strategies developed by human herpesviruses.
Vandevenne P; Sadzot-Delvaux C; Piette J
Biochem Pharmacol; 2010 Dec; 80(12):1955-72. PubMed ID: 20620129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
